WCN25-3303 REASSURING USAGE OF SGLT-2I AND RAASB IN INDIAN PATIENTS WITH TYPE 2 DIABETES AND CKD: A NATIONWIDE CROSS SELECTION STUDY (CITE 1)

Lignende værker

• WCN25-3303 REASSURING USAGE OF SGLT-2I AND RAASB IN INDIAN PATIENTS WITH TYPE 2 DIABETES AND CKD: A NATIONWIDE CROSS SELECTION STUDY (CITE 1)
  af: Samit Ghosal, et al.
  Udgivet: (2025-02-01)
• WCN25-3304 INCREASED RISK OF HF AND RETINOPATHY WITH ADVANCED CKD BUT NOT WITH ASCVD IN PATIENTS WITH T2D (CITE 2 STUDY)
  af: Samit Ghosal, et al.
  Udgivet: (2025-02-01)
• The reversal model for metabolic syndrome (RMMS) study: The rationale and design
  af: Subhajyoti Ghosh, et al.
  Udgivet: (2022-01-01)
• IRWIS (IDegLira Real world Indian Study): A Real-World Observational Study For Use of IDegLira In Indian Patients
  af: Kalyan Kumar Gangopadhyay, et al.
  Udgivet: (2020-11-01)
• Re-imagining Oral Semaglutide in Routine Clinical Practice: Indian Expert Panel Recommendations
  af: Aravinda Jagadeesha, et al.
  Udgivet: (2025-07-01)